CN Mobile Logo

Search form


Posaconazole reduces infection in AML patients

Posaconazole reduces infection in AML patients

The incidence of pneumonia and invasive pulmonary aspergillosis in acute myeloid leukemia patients was reduced when they were given posaconazole (Noxafil) as prophylaxis.

According to a study presented at the 2009 Interscience Conference on Antimicrobial Agents and Chemotherapy in San Francisco, the number of febrile days, incidence rates of invasive fungal diseases and aspergillosis, and duration of hospitalization decreased significantly (abstract 1052).

Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.